Synthesis and biological activity of nitrogen-containing derivatives of methyl dehydroabietate

Pharmaceutical Chemistry Journal

Volumn 40, Issue 9, 2006, Pages 489-493

  Tolmacheva, I A ^a   Tarantin, A V ^a   Boteva, A A ^a   Anikina, L V ^a   Vikharev, Yu B ^a   Grishko, V V ^a   Tolstikov, A G ^a  

^a INSTITUTE OF TECHNICAL CHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

12 (3 CHLOROPROPIONYL) 8,11,13 ABIETATRIEN 18 OATE; 12 ACETYL 8,11,13 ABIETATRIEN 18 OATE; 12 BROMOACETYL 8,11,13 ABIETATRIEN 18 OATE; 12 MORPHOLINOACETYL 8,11,13 ABIETATRIEN 18 OATE; 12 MORPHOLINOPROPIONYL 8,11,13 ABIETATRIEN 18 OATE; 12 N METHYLPIPERAZINOACETYL 8,11,13 ABIETATRIEN 18 OATE; 12 N METHYLPIPERAZINOPROPIONYL 8,11,13 ABIETATRIEN 18 OATE; 12 N,N DIETHYLAMINOACETYL 8,11,13 ABIETATRIEN 18 OATE; 12 N,N DIETHYLAMINOPROPIONYL 8,11,13 ABIETATRIEN 18 OATE; 12 PIPERIDINOACETYL 8,11,13 ABIETATRIEN 18 OATE; 12 PIPERIDINOPROPIONYL 8,11,13 ABIETATRIEN 18 OATE; ANTIPYRETIC AGENT; ANXIOLYTIC AGENT; CAFFEINE BENZOATE; DEHYDROABIETIC ACID; DIAZEPAM; DIPYRONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPYRETIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DRUG SYNTHESIS; LD 50; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; RAT; TRANQUILIZING ACTIVITY;

EID: 33847788269     PISSN: 0091150X     EISSN: 15739031     Source Type: Journal    
DOI: 10.1007/s11094-006-0161-0     Document Type: Article

References (18)

1. W. Gottstein and L. Cheny, J. Org. Chem, 30(6), 2072-2073 (1965).
2. Z. Guangyou, L. Yuquing, W. Zhaohui, et al., Tetrahedron: Asymmetry, 14, 3297-3300 (2003).
3. Le-Van-Thoi and A. Belloc, Ind. Plast. Mod., 6(3), 90-92 (1954).
4. H. Wada, S. Kodato, M. Kawamori, et al., Chem. Pharm. Bull., 33, 1472-1487 (1985).
5. T. Minami, S. Mada, H. Tokuda, et al., J. Nat. Prod., 12, 1921-1923 (2002).
6. J. R. Tagat, D. V. Nazareno, M. S. Puar, et al., Biochem. Med. Chem. Lett., 4(9), 1101-1104 (1994).
7. Y. Fujita, Y. Yoshikuni, T. Sotomatsu, et al., Chem. Pharm. Bull., 39(5), 1193-1198 (1991).
8. Chech Patent No. 106250b (1961); Ref. Zh. Khim., 13N 203P (1964).
9. L. F. Fieser and W. P. Campbell, J. Am. Chem. Soc C, 61, 2528-2534 (1939).
10. M. T. Irismetov, G. A. Tolstikov, and M. I. Goryaev, Izv. Akad. Nauk Kaz. SSR, Ser. Khim., No. 6, 42-45 (1969).
11. Laboratory Techniques in Organic Chemistry [in Czech], B. Keil (ed.), Prague (1963).
12. N. J. Halbrook and R. V. Lawrence, J. Org. Chem., 31, 4246-4247 (1966).
13. L. F. Fieser and W. P. Campbell, J. Am. Chem. Soc C, 60, 2631-2636 (1939).
14. V. B. Prozorovskii, M. P. Prozorovskaya, and V. M. Demchenko, Farmakol. Toksikol., 41(4), 497-502 (1978).
15. I. R. Bossier, P. Simon, and I. M. Zwolf, Therapie, 19(3), 571-583 (1964).
16. I. P. Lapin and S. M. Mirzaev, Byull. Eksp. Biol. Med., No. 3, 355-356 (1996).
17. Methodological Recommendation on the Experimental (Preclinical) Investigation of Nonsteroidal Antiinflammatory Pharmaceuticals [in Russian], F. P. Trinus and B. M. Klebanov (eds.), Pharmacological Committee of the USSR Ministry of Public Health, Moscow (1982).
18. M. L. Belen'kii, Elements of the Quantitative Assessment of the Pharmacological Effect [in Russian], Medgiz, Leningrad (1963).